Fill Finish Biopharmaceuticals market Share, Growth Analysis by 2035 Given the growing pipeline of biologics, lack of technical expertise, and huge capital investment in the installation of fill / finish equipment, a number of drug manufacturers are turning to contract service providers in order to ensure the development of quality drug products. This evident surge in the demand for biologics fill and finish services has presented lucrative opportunities for service providers having necessary fill / finish capabilities. The financial opportunity within the biologics fill finish services market has been analysed across the following segments:  Type of Packaging Container  Ampoules  Cartridges  Syringes  Vials  Type of Biologic  Antibodies  Cell Therapies  Gene Therapies  Oligonucleotides  Proteins / Peptides  Vaccines  Others  Therapeutic Area  Oncological Disorders  Autoimmune Disorders  Infectious Diseases  Cardiovascular Disorders  Other Disorders  Scale of Operation  Preclinical / Clinical  Commercial  Company Size  Large  Mid-sized  Small  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America The “Biologics Fill / Finish Services Market (3rd Edition), 2022 – 2035” report features the following companies, which we identified to be key players in this domain:  AbbVie Contract Manufacturing  Asymchem  BioReliance  Boehringer Ingelheim BioXcellence  Catalent Biologics  Charles River Laboratories  Fareva  Fresenius Kabi  Glaxo SmithKline  Hetero Drugs  Intas Pharmaceuticals  Lonza  Patheon  Pierre Fabre  Recipharm  Samsun Biologics  Syngene  Takara Bio  Wacker Biotech  WuXi AppTec  WuXi Biologics Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Biologics Fill / Finish Service Providers: Market Landscape 5. Company Competitiveness Analysis 6. Biologics Fill / Finish Service Providers in North America 7. Biologics Fill / Finish Service Providers in Europe 8. Biologics Fill / Finish Service Providers in Asia-Pacific 9. Recent Partnerships 10. Recent Expansions 11. Capacity Analysis 12. Demand Analysis 13. Key Performance Indicators for Biologic Manufacturing and Fill / Finish 14. Regional Capability Assessment 15. Biologics Fill Finish Market Sizing and Opportunity Analysis 16. Future Growth Opportunities 17. Case Study: Robotic Systems in Fill / Finish Operations 18. Case Study: Ready-To-Use Packaging Components for Aseptic Fill / Finish 19. Concluding Remarks 20. Executive Insights 21. Appendix 1: Tabulated Data 22. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/view_document/biologics-fill-finish-services-market/256.html News article women's digital health market Learn from experts: do you know about these emerging industry trends? Bioavailability Enhancement Technologies TIL Therapies: A New Paradigm in Cancer Treatment Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #FillFinishManufacturing #FillFinishManufacturingMarket #BiologicsFillFinish #MarketResearch #MarketInsights

Antibody Drug Conjugate market Size, Share, Trends by 2035 The potential of antibody drug conjugates for the treatment of various disease indications, including cancer, is being slowly recognized in the pharmaceutical sector. Specifically, the success of these products can be attributed to their ability to effectively identify and eliminate diseased cells, along with low risk of side effects. The financial opportunity within the antibody drug conjugate market has been analyzed across the following segments:  Target Disease Indication  Acute Lymphoblastic Leukemia  Breast Cancer  B-Cell Lymphoma  Cervical Cancer  Gastric Cancer  Lung Cancer  Multiple Myeloma  Renal Cancer  Other Target Disease Indications  Therapeutic Area  Hematological Cancer  Solid Tumor  Linker  Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (Acbut)  Maleimide  Maleimidocaproyl  Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate  Tetrapeptide-Based Linker  Valine-Alanine  Valine-Citrulline  Other Linkers  Payload  DM1  DM4  Duocarmycin  Monomethyl auristatin E (MMAE)  Monomethyl auristatin F (MMAF)  Ozogamicin  SG3199  SN-38 / Irinotecan  Other Payloads  Target Antigen  BCMA (TNFRSF17 / BCM)  CD19  CD22  CD30  CD79b  CEACAM5  HER-2 (ERBB2)  Nectin 4  Tissue factor  TROP-2  Other Target Antigen  Key Geographical Regions  North America  Europe  Asia-Pacific and Rest of the World The Antibody Drug Conjugate Market (7th Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:  ADC Therapeutics  Astellas Pharma  AstraZeneca  Byondis  Daiichi Sankyo  Genentech  Gilead Sciences  ImmunoGen  Pfizer  RemeGen Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Target Competitiveness Analysis 6. Company and Drug Profiles 7. Clinical Trial Analysis 8. Key Opinion Leaders 9. Combination Therapies 10. Partnerships and Collaborations 11. Funding and Investment Analysis 12. Patent Analysis 13. Academic Grants Analysis 14. Key Commercialization Strategies 15. Promotional Analysis 16. Success Protocol Analysis 17. Novel Conjugation and Linker Technology Platforms 18. Assessment of Non-Clinical Data First in Human Dosing 19. Cost Price Analysis 20. Case Study 1: Contract Manufacturing of Antibody-Drug Conjugates 21. Case Study 2: Companion Diagnostics for Antibody-Drug Conjugate Therapeutics 22. SWOT Analysis 23. Market Sizing and Opportunity Analysis 24. Executive Insights 25. Conclusion 26. Appendix 1: Tabulated Data 27. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/view_document/antibody-drug-conjugates-market/270.html Learn from experts: do you know about these emerging industry trends? Digital Therapies: The “Digital Pills” of current generation Medical Device Coatings and Modification Technologies Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #ADCMarket #antibodydrugconjugate #antibodydrugconjugatemarket #MarketResearch #MarketInsights

Intracellular Drug Delivery market Growth Analysis and Forecast by 2035 The growing demand for novel drugs that can acts as potential treatments for previously untreatable intracellular targets has resulted in an adjacent and urgent need for efficient delivery systems that facilitate intracellular transport of therapeutics across the cytosol The financial opportunity within non-viral drug delivery systems market has been analyzed across the following segments:  Type of Molecule  Small Molecule  Biologic  Type of Biologic  Antibodies  DNA  RNA  Proteins / Peptides  Type of Intracellular Drug Delivery Technologies  Cell Penetrating Peptides  Extracellular Vesicles  Oligonucleotides  Nanoparticles  Polymers  Target Therapeutic Area  Infectious Diseases  Oncological Disorders  Genetic Disorders  Neurological Disorders  Hepatic Disorders  Cardiovascular Disorders  Other Disorders  Type Of Payment Model  Upfront Payments  Milestone Payments  Key Geographical Regions  North America  Europe  Asia  Latin America  Middle East and North Africa (MENA)  Rest of the world The Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035, report features the following companies, which we identified to be key players in this domain:  Alnylam Pharmaceuticals  AstraZeneca  Biond Biologics  Code Biotherapeutics  Eli Lilly  Merck  Novartis  Roche Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Key Insights 6. Company Competitiveness Analysis 7. Company Profiles 8. Patent Analysis 9. Partnerships and Collaborations 10. Opportunity Assessment Framework 11. Market Forecast 12. Conclusion 13. Executive insights 14. Appendix I: Tabulated data 15. Appendix II: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html News article AI-based Digital Pathology Market Learn from experts: do you know about these emerging industry trends? Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic? Exploring How Artificial Intelligence Is Transforming Digital Pathology About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #nonviraldrugdeliverysystemmarket #Intracellularbiologics #intracellulardelivery #MarketResearch #MarketInsights

Women Digital Health market Share, Growth Analysis by 2035 The growing popularity of digital solutions has enabled the development of technological remedies, such as mobile apps, software, wearable devices and diagnostic tools that exclusively aid in improving female health and wellness. Owing to the increased adoption rate of digital solutions and rise in the demand for remote healthcare services, the companies involved in the women’s digital health domain have witnessed a surge in the investment activity. Further, taking into consideration both the historical and modern scenarios, we expect the women’s digital health market to offer numerous lucrative investment opportunities. The financial opportunity within the women’s digital health market has been analyzed across the following segments:  Type of Solution  Applications / Software  Devices  Services  Therapeutic Application Area  Fetal Health  General Wellness  Menstrual Cycle  Pelvic Care  Reproductive Health / Fertility  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa  The Investor Series: Opportunities in Women’s Digital Health Market, features detailed profiles of the key public ventures engaged in the development of women’s digital health solutions; each profile features a brief overview of the company, details on its management team, insights from its balance sheet (if available), details on its product / service portfolio, recent developments and key financial details (including company investment highlights, company fundamental and company technical analysis). A detailed analysis of the women's digital health funding and women's digital health investment activity that has taken place, since 2011. Table of Contents Excel Deliverables 1. Innovators and Product Dataset 2. Funding and Investment Analysis 3. Fundamental and Technical Financial Analysis 4. Market Forecast and Opportunity Analysis 5. Return on Investment PowerPoint Deliverable 1. Context 2. Project Objectives 3. Project Approach 4. Executive Summary Section I: Introduction to Women’s Digital Health Solutions and Innovator Landscape 5. The Women’s Digital Health Market 6. Women’s Digital Health: Innovator Landscape 7. Women’s Digital Health: Product Landscape and Company Health Indexing 8. Value Proposition Analysis 9. Company Competitiveness Analysis Section II: Analysis of Investments 10. Funding and Investment Analysis Section III: Financial Analysis of Key Public Ventures 11. Financial Analysis of Public Ventures 12. Company Profiles of Public Ventures Section IV: Market Forecast and Opportunity Analysis 13. Market Forecast and Opportunity Analysis Section V: Key Acquisition Targets, Business Risk Assessment and Return on Investments 14. Key Acquisition Targets 15. Business Risk Assessment 16. Return on Investments 17. Conclusion 18. Appendices Get more details on the report https://www.rootsanalysis.com/reports/opportunities-in-women-digital--health-market.html Learn from experts: do you know about these emerging industry trends? mRNA Synthesis: Manufacturing Process of Modern Revolutionary Molecule TIL Therapies: A New Paradigm in Cancer Treatment Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #WomensDigitalHealth #womensdigitalhealthsolutions #digitalhealth #MarketResearch #MarketInsights

Analysis of modular manufacturing market Strategies and Forecasts to 2035 Modular facilities can be an effective way for drug developers and manufacturers to reduce costs, minimize delays, and expedite time-to-market, by utilizing the available infrastructure while operating in accordance with the standard GMP guidelines The financial opportunity within modular facilities market has been analyzed across the following segments:  Size of Facility  Small Plants  Mid-sized Plants  Large Plants  Very Large Plants  Type of Industry Served  Pharmaceutical  Biotechnology  Type of Modular Construct  Hybrid Skid Modular Constructs  Plug-and-Play Modular Constructs  Skid-Mounted Modular Constructs  Truckable Modular Constructs  Others Modular Constructs  Type of Construction Component  Process Equipment  Base Building  Mechanical, Electrical and Plumbing System  Process Commodities  Other Construction Components  Type of Facility  Manufacturing  Aseptic Filling  Research and Development  Others  Scale of Operation  Clinical  Commercial  Type of Product  Cell and Gene Therapies  Vaccines  Biosimilars  Monoclonal Antibodies  Advanced Pharmaceuticals  Sterile Products  Viral Vectors  Other Products  Type of Expansion  New Facilities  Facility Expansions  Planned Expansions  Type of Modular Construction  Relocatable  Permanent  Type of Material  Steel  Wood  Concrete  Key Geographical Regions  North America  Europe  Asia  Middle East and North Africa (MENA)  Rest of the world The Modular Facilities in the Pharmaceutical and Biotech Market, 2023-2035, report features the following companies, which we identified to be key players in this domain:  Cytiva  G-CON Manufacturing  Germfree  IPM Technologies  KeyPlants  ModuleCo Pharma  NNE  Pharmadule Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape: Modular Facility Manufacturers 5. Market Landscape: Modular Cleanroom Providers 6. Modular Facility Manufacturers: Company Competitiveness Analysis 7. Company Profiles 8. Partnerships and Collaborations 9. Case Study on Modular Projects in Pharmaceutical and Biotechnology Industry 10. Facility Construction Trends in the Pharmaceutical Industry 11. Cost, Time Optimization Framework 12. Market Forecast 13. Prevalent and Emerging Trends 14. Future Growth Opportunities 15. Conclusion 16. Executive insights 17. Appendix I: Tabulated data 18. Appendix II: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/modular-manufacturing-market/178.html Learn from experts: do you know about these emerging industry trends? Investment Opportunities in Women’s Digital Health Genotoxicity Testing: Unlocking the Future Safety Assessment Opportunities Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #modularcleanroom #modularcleanroommanufacturers #modularconstructionmarket #MarketResearch #MarketInsights

Dental 3D Printing market Growth Analysis and Forecast by 2035 The popularity of 3D printing technology within the dental industry can be attributed to its ability to print high quality / accurate dental products, including crowns, bridges, dentures, dental implants and surgical guides. Driven by the overall growth of the additive manufacturing (3D printing) industry, and wide adoption of 3D printers in the dental sector, the dental 3D printing market is anticipated to witness a steady growth in the foreseen future. The financial opportunity within the SMOs market has been analyzed across the following segments:  Type of Printing Technology  VAT Polymerization Technology  Powder Bed Fusion Technology  Polyjet Technology  Metal Extrusion Technology  Other Technologies  Application Area  Prosthodontics  Orthodontics  Dental Implants  Other Applications  Type of Printing Material  Resins  Plastics  Metals  Metals  Other Material  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa  Rest of the World The Dental 3D Printing Market, 2022 – 2035 report studies dental 3D printers manufacturers in detail and features the following companies, which we identified to be key players in this domain:  3D Systems  Asiga  BEGO  Carbon  Digital Wax Systems (DWS)  Formlabs  Prodways  Rapid Shape  SprintRay  Stratasys Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Product Competitive Analysis 6. Company Profiles 7. Partnerships and Collaborations 8. Patent Analysis 9. Bowman Clock Pricing 10. Market Forecast and Opportunity Analysis 11. Concluding Remarks 12. Executive Insights 13. Appendix 1: Tabulated Data 14. Appendix 2: List of Companies And Organizations Get more details on the Dental 3D Printing Market report https://www.rootsanalysis.com/reports/dental-3d-printing-market.html Learn from experts: do you know about these emerging industry trends? Digital Therapies: The “Digital Pills” of current generation Medical Device Coatings and Modification Technologies About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #3dprinteddentalimplants #3d printingdentalimplants #dental3dprinting #MarketResearch #MarketInsights

Latest news on Exosome Therapeutics market Research Report by 2035 Driven by the development of novel platforms and advanced technologies along with consistent efforts of the stakeholders in research and development of exosome therapeutics which is set to see some FDA approved therapies in this decade A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Therapeutic  Allogeneic Therapy  AutologousTherapy  Target Indication(s)  Degenerative Meniscal Injury  Dystrophic Epidermolysis Bullosa  Fistula Perianal  Retinitis Pigmentosa  Therapeutic Area  Dermatological Disorders  Muscoskeletal Disorders  Ophthalmic Diseases  Rectal Disorders  Route of Administration  Fistula Tract  Intra-articular  Intra-ocular  Geography  North America  Europe  Asia-Pacific and Rest of the World The Exosome Therapeutics Market, 2022-2040 report features the following companies, which we identified to be key players in this domain:  Codiak BioSciences  Coya Therapeutics  Curexsys  EV Therapeutics  Evox Therapeutics  SHIFTBIO  AEGLE Therapeutics  AVEM Healthcare  Cellular Biomedicine Group  OBCTCD24  ReNeuron  Stem Cell Medicine Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Company Profiles 6. Drug Profiles 7. Clinical Trial Analysis 8. Academic Grants Analysis 9. Global Event Analysis 10. Partnerships and Collaborations 11. Funding and Investments 12. Start-up Health Indexing 13. Case Study: Exosome Development and Manufacturing Service Providers 14. Drug Failure Analysis 15. Market Forecast 16. Executive Insights 17. Appendix 1: Tabulated Data 18. Appendix 2: List of Companies and Organizations Key Questions Answered  Who are the leading industry and non-industry players engaged in the development of exosome therapy?  Which are the key drugs being developed across early and late stages of development?  What are the key agendas being discussed in various global events / conferences related to exosomes?  What kind of partnership models are commonly adopted by industry stakeholders?  Which are the leading funding institutes / centers supporting the research related to exosome therapies?  Which geographies are the most active in conducting clinical trials related to exosome therapeutics?  How is the current and future market opportunity, related to exosome therapies likely to be distributed across key market segments? To view more details on this report, click on the link https://www.rootsanalysis.com/reports/exosome-therapeutics-market.html News article Smart Pharmaceutical and Healthcare Labels Market Learn from experts: do you know about these emerging industry trends? Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities Digital Therapies: The “Digital Pills” of current generation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #exosometherapy #exosomediagnostics #exosomecompanies #MarketResearch #MarketInsights

Filtration market Analysis and Trends by 2023-2035 The biopharmaceutical filtration market has been growing rapidly in recent years, driven by the increasing demand for biologics, as well as advances in filtration technologies. It is a critical step in the manufacturing process of biopharmaceutical products, and its applications are essential in ensuring the safety, quality, and efficacy of the final product. The financial opportunity within the biopharmaceutical market has been analyzed across the following segments:  Type of Filtration System  Depth Filtration System  Tangential Flow Filtration Systems  Membrane Filtration System  Other Filtration Systems  Type of Filter (based on use)  Disposable / Single-use Filters  Reusable / Multi-use Filters  Type of Assembly  Capsules  Cartridges  Others  Type of Drug Product  Antibodies  Vaccines  Recombinant Proteins  Cell Therapies  Gene Therapies  Oligonucleotides  Others  Company Size  Small / Mid-sized  Large  Key Geographical Regions  North America  Europe  Asia-Pacific  Rest of the World The “Global Filtration Market (Focus on Biologics Manufacturing), 2023 – 2035” report features the following companies, which we identified to be key players in this domain:  Asahi Kasei  Cobetter Filtration  Corning  Merck  Pall  Parker Hannifin  Sartorius  Thermo Fisher Scientific Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Biopharmaceutical Filtration: Market Landscape 5. Company Competitiveness Analysis 6. Suppliers Headquartered in North America: Company Profiles 7. Suppliers Headquartered in Europe and Asia-Pacific: Company Profiles 8. Recent Developments 9. Global Events Analysis 10. Biopharmaceutical Filtration: Market Forecast and Opportunity Analysis 11. Conclusion 12. Executive Insights 13. Appendix 1: Tabulated Data 14. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/global-filtration-market.html Learn from experts: do you know about these emerging industry trends? TCR Therapies: An Emerging Therapeutic Modality Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #membranefiltrationmarket #membranefiltrationsystem #pharmaceuticalfiltrationmarket #MarketResearch #MarketInsights

Latest news on Cell and gene therapy CRO market Research Report by 2035 Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell and Gene Therapy CROs Market, 2022-2035”. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:  A detailed overview of the overall market landscape of the cell and gene therapy CROs, based on several relevant parameters, such as year of establishment, company size, location of headquarters, area of expertise, scale of operation and types of services offered.  A detailed analysis on the business models that are commonly adopted by the biopharmaceutical industry for outsourcing cell and gene therapies.  Elaborate profiles of key industry players based in North America, Europe and Asia-Pacific that offer contract research services.  A benchmark analysis of the various players engaged in this domain. It highlights the capabilities of the companies.  An analysis of the recent collaborations within the cell and gene therapy contract research industry, during the period 2015-2022.  A detailed analysis of the various mergers and acquisitions that have taken place in this domain, during the period 2015-2022.  A detailed acquisition target analysis, taking into consideration historical trend of the activity of players that have acquired other firms since 2015.  A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution highlighting the relative effect of each SWOT parameter on the overall cell and gene therapies research services industry.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Area of Expertise  Cell Therapy  Gene Therapy  Scale of Operation  Preclinical  Clinical  Drug Discovery  Therapeutic Area  Oncological Disorders  Neurological Disorders  Cardiovascular Disorders  Infectious Diseases  Metabolic Disorders  Autoimmune Disorders  Blood Disorders  Rare / Genetic Disorders  Ophthalmic Disorders  Other disorders  Analysis by Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa Key companies covered in the report  Altasciences  Charles River Laboratories  Creative Biolabs  IQVIA  Medpace  PPD  Precision for Medicine  Accelera  Evotec  ICON  Syneos Health  CMIC Group  Labcorp To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html News article AI-based digital pathology market Learn from experts: do you know about these emerging industry trends? TCR Therapies: An Emerging Therapeutic Modality Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #atmps #genetherapycro #cellandgenetherapycompanies #MarketResearch #MarketInsights

Lab Automation market Share, Growth Analysis by 2035 The diverse applications of lab automation systems, including advanced data management, high reproducibility and increased productivity in the biotechnology and pharmaceutical industries, have allowed the researchers to focus on more complex tasks. As a result, several stakeholders have been engaged in the manufacturing of user-friendly, controlled and automated instruments that can be customized as per the needs of the laboratory. The USD 7.5 billion (by 2035) financial opportunity within the lab automation market has been analyzed across the following segments:  Stage of Automation  Pre-Analytical  Analytical  Post-Analytical  Total Lab Automation  Type of Instrument  Automated Liquid Handling Systems  Automated Microplate Readers  Automated Sampling Systems  Analyzers  Automated Storage and Retrieval Systems (ASRS)  Other Instruments  End-User  Pharmaceutical and Biotechnology Companies  Research and Diagnostic Laboratories  Other End-Users  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America The Lab Automation Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:  Abbott  Anton Paar  BD  Beckman Coulter  ERWEKA  Leuze  Ortho Clinical Diagnostics  Pall Corporation  PerkinElmer  Roche Diagnostics  Siemens Healthineers  SYSTAG Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Company Competitiveness Analysis 6. Company Profiles 7. Partnerships and Collaborations 8. Patent Analysis 9. Market Forecast and Opportunity Analysis 10. Case Study: Lab Automation Software 11. Executive Insights 12. Appendix 1: Tabulated Data 13. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/lab-automation-market.html News article Biopharmaceutical Filtration Market Learn from experts: do you know about these emerging industry trends? CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications T-cell Immunotherapies: The Future of Modern Cancer Treatments Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #labautomation #laboratoryautomation #laboratoryautomationmarket #MarketResearch #MarketInsights